Hernan Parra Suspended 15 Days After Dexamethasone Positives, Fined $2,500

Hernan H. Parra received a 15-day period of ineligibility beginning February 20, 2026, and a $2,500 fine after post-race tests found the corticosteroid dexamethasone in two horses that raced at Gulfstream Park. The Horseracing Integrity & Welfare Unit cited Rule 3312 - Presence of a Controlled Medication Substance - and ordered disqualification of the covered horses’ race results and forfeiture of earnings; the suspension runs through March 6, 2026, and Parra was assigned 1.5 penalty points.

The positive tests involved Nadir Han and Justy Han, both owned by Guillermo Rangel. Nadir Han’s post-race sample from a maiden optional claiming at Gulfstream Park on 12/13/2025 tested positive for dexamethasone; Nadir Han was making his third career start and finished eighth in that race. Justy Han’s post-race sample from his debut at Gulfstream Park on 1/3/2026 also tested positive for dexamethasone; Justy Han is a 4-year-old colt who finished seventh in that race.

HIWU’s case entries show a date of resolution of 2/19/2026 for the matters involving those covered horses, and the formal penalty period began the next day on 2/20/2026. The ruling language includes standard disqualification and forfeiture provisions - repayment or surrender of purses and other compensation - and notes that “The following cases are treated as one violation.” HIWU treated the two positives as a single violation because the second positive occurred before Parra had been notified of the first and both involved the same medication.

Parra “agreed that he violated the Anti‑Doping and Medication Control rules enforced by the Horseracing Integrity and Welfare Unit and accepted the penalties.” The case adds to Parra’s recent medication history; he has had three violations involving a class C controlled medication within a two-year period. A prior penalty last August resulted in a seven-day suspension and a $1,000 fine for a phenylbutazone positive in Mischievous Han, another horse owned by Guillermo Rangel.

Dexamethasone was designated a class C controlled substance in the rulings; the medication is described as a corticosteroid commonly given as an anti-inflammatory for respiratory disease or for inflammation in joints. The available case documents do not include laboratory concentration values, detection thresholds, the testing laboratory name, or the exact purse amounts to be forfeited for the 12/13/2025 and 1/3/2026 races.

With the 15-day ineligibility running Feb. 20 through March 6, Parra will be barred from licensed activity during that span and the two covered race results are formally subject to disqualification and forfeiture. Remaining questions for follow up include the precise sums to be repaid from the Gulfstream Park cards on 12/13/2025 and 1/3/2026, the exact date Parra was first notified of the Nadir Han positive, and whether any appeal or further administrative action will be filed.